Merck KGaA agrees to acquire Silence Therapeutics for over $1 billion
FROM THE WIRE · FINANCE.YAHOO.COM
Silence Therapeutics stock surges as Merck KGaA agrees to acquire the RNA drugmaker for over $1 billion. Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA deal above $1 billion in biotech lifts the target and signals interest in RNA drugs.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Merck KGaA agrees to acquire RNA drugmaker Silence Therapeutics.
- 02The deal value exceeds $1 billion.
- 03Silence Therapeutics stock surges on the news.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Silence Therapeutics plc19.59 USD0.00%today +125.63%Positive Merck KGaA144.35 EURMarket closedtoday +0.03%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets